According to current dogma, there is little or no ongoing neurogenesis in the fully developed adult enteric nervous system. This lack of neurogenesis leaves unanswered the question of how enteric neuronal populations are maintained in adult guts, given previous reports of ongoing neuronal death. Here, we confirm that despite ongoing neuronal cell loss because of apoptosis in the myenteric ganglia of the adult small intestine, total myenteric neuronal numbers remain constant. This observed neuronal homeostasis is maintained by new neurons formed in vivo from dividing precursor cells that are located within myenteric ganglia and express both Nestin and p75NTR, but not the pan-glial marker Sox10. Mutation of the phosphatase and tensin homolog gene in this pool of adult precursors leads to an increase in enteric neuronal number, resulting in ganglioneuromatosis, modeling the corresponding disorder in humans. Taken together, our results show significant turnover and neurogenesis of adult enteric neurons and provide a paradigm for understanding the enteric nervous system in health and disease.
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enteric neurons | adult neurogenesis | Nestin | enteric neural precursor cells | neuronal apoptosis T he enteric nervous system (ENS) controls or regulates vital gastrointestinal functions, including motility, secretion, local immunity, and inflammation, and represents the largest collection of autonomous neurons outside of the brain (1) . Disorders involving the ENS are common and major contributors to the health burden throughout the world (2) . Although the ENS is constantly exposed to mechanical stress (3), as well as potential environmental threats from luminal contents (4), it is not known how the numbers of enteric neurons in the healthy adult small intestine remain remarkably constant for most of adult life (5) . Although continuous production of new neurons in the gut would appear to be needed to offset the observed apoptosis-mediated neuronal loss (6) , such neurogenesis has been remarkably difficult to demonstrate and in vivo enteric neurogenesis in adults remains highly controversial (7) (8) (9) (10) . A second and related conundrum in this field has been the inability to confidently determine if a true enteric neural precursor cell (ENPC) exists in the gut, despite ample demonstration of stem-cell like behavior (self-renewal and multipotency) in vitro of cells isolated from embryonic and adult intestine using a variety of markers (7) (8) (9) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . In this study, we have resolved these controversies by successfully identifying the ENPC capable of rapid neurogenesis in vivo to keep up with what we show to be a high rate of ongoing neuronal apoptosis in the adult small intestine. Furthermore, unchecked proliferation of these precursor cells leads to an intestinal phenotype that resembles human ganglioneuromatosis, a disorder of intestinal dysmotility seen in patients (24) . Our results indicate a remarkable rate of turnover of adult neurons in the small intestine and provide a unique paradigm for understanding the ENS in health and disease.
Results
Significant Neuronal Loss Occurs in the ENS in the Healthy Adult Gut.
We determined if enteric neurons are dying at a significant rate in healthy adults, thus establishing the need for replacement by neurogenesis. First, we stained adult murine myenteric ganglia with a cleaved caspase-3-specific antibody that has previously been shown to mark neurons from the central and ENS that are fated for apoptosis (25, 26) . We found that a significant
Significance
The demonstration of a robust neurogenesis program in the adult gut and the existence of an enteric neural precursor cell (ENPC) responsible for the same has profound biological and clinical implications. This demonstrates the presence of robust adult neurogenesis outside of the CNS, and indicates the vulnerability of the enteric nervous system to exogenous influences, even in adults. As an example, it is possible that acquired diseases of the enteric nervous system, such as achalasia, may result from a loss of ENPC, analogous to congenital disorders, such as Hirschsprung's. The ability to identify the adult ENPC will therefore enable a new understanding of the pathogenesis of enteric neuromuscular diseases as well as the development of novel regenerative therapies.
number (mean ± SE of percent cleaved caspase-3 + neurons per ganglia = 11.49 ± 0.50, total numbers of ganglia counted = 48, from 3 adult mice) of myenteric neurons express the enzyme cleaved caspase-3 (Fig. 1A) . The presence of significant levels of apoptotic neurons by this method in the young adult myenteric plexus was recently confirmed in an independent publication (27) . Biochemical proof of the enzymatic activity of caspase-3 was then obtained using a fluorescently labeled caspase-3/7 substrate (Fig. 1C) (28) , accompanied by in vivo labeling of myenteric neurons with propidium iodide (PI), which is indicative of dying cells (Fig. 1B and Fig. S1 A and B) (29) (30) (31) .
Further proof of the limited longevity of adult enteric neurons was obtained using a nitric oxide synthase 1 (NOS1)-creER T2 mouse, which we have previously reported (32) . This mouse was bred with a mouse containing a floxed tdTomato gene and the resulting NOS1-creER T2 :tdTomato progeny were administered tamoxifen (for 4 consecutive days) when adults. In mice that were killed immediately after induction (day 0), almost all NOS1-expressing neurons were labeled with tdTomato expression (Fig.  2A) . However, in mice that were killed 7 d after the tamoxifen treatment, we observed the emergence of a population of NOS1-expressing neurons that were not labeled with tdTomato (Fig. 2B) , suggesting that these NOS1-expressing neurons were newly born. This observed loss of tdTomato-labeled nitrergic (NOS1 + ) neurons was corroborated using our previously described technique of in vivo imaging (32) . On imaging the same myenteric region of live NOS1-creER
T2
:tdTomato mice that were induced as before with tamoxifen, we observed a loss of labeled neurons within a 24-h period, accompanied by robust remodeling of neural networks (Fig.  2C) . However, even with the observed loss of nitrergic neurons over the course of 7 d, the total number of neurons within myenteric ganglia was conserved (Fig. 2F) :tdTomato mouse that was killed the day after the cessation of tamoxifen induction (day 0) and stained with antisera against NOS1 (green) (A) and another that was killed 7 d after the cessation of tamoxifen induction (B). At day 0 (A), all NOS1-expressing neurons express tdTomato (yellow arrows), whereas at day 7 (B), a population of NOS1-expressing neurons that do not express tdTomato emerges (blue arrows). Nuclei are labeled in B with DAPI (blue). (Scale bars, 10 μm.) (C) A 2D projection of 3D images captured using live animal two-photon microscopy [(i) time 0 and (ii) time 24 h] from the same region of the myenteric plexus of NOS1-creER T2 :tdTomato mouse that was induced with tamoxifen before the imaging shows the disappearance of a tdTomato + nitrergic neuron (green arrow) within 24 h. The image also shows (white arrow) the appearance of new projections from a tdTomato + neuron that rapidly extend to form new network connections within 24 h, showing the robust plasticity of neuronal networks in the myenteric ganglia. (Scale bars, 10 μm.) (D and E) Representative images from myenteric ganglia that were stained with antisera against HuC/D (green) and antibody against cleaved caspase-3 (red) shows a lack of cleaved caspase-3 immunoreactivity in mice that were given the pan-caspase inhibitor zVAD-FMK (E), whereas mice that were not given the drug shows the presence of cleaved caspase-3-labeled myenteric neurons (yellow arrow in E). (Scale bars, 10 μm.) (F) Quantification of numbers of tdTomato + and HuC/D expressing neurons within myenteric ganglia from three different cohorts of mice killed at day 7 shows a significant reduction (*P < 0.05) in the numbers of tdTomato + neurons per ganglia in mice without zVAD-FMK compared with either day 0 or those given zVAD-FMK. The data also shows that total numbers of HuC/D + neurons within myenteric ganglia remain conserved between days 0 and 7 (without zVAD-FMK) although the numbers of tdTomato + neurons dwindle.
Furthermore, an attenuation of apoptosis brought about by zVAD-FMK administration results in a concomitant significant increase in total numbers of myenteric neurons per ganglia ( # P < 0.05) compared with the other two groups. myenteric ganglia were reduced by ∼31% at day 7: 3.70 ± 0.38; compared with mice at day 0: 5.31 ± 0.42, P = 0.003).
To determine whether the observed loss of mature tdTomato + neurons was because of apoptosis, we repeated the above experiment in another cohort of NOS1-creER
:tdTomato mice, this time treated with the pan-caspase inhibitor zVAD-FMK for 7 d, which suppressed the formation of cleaved caspase-3 within the adult myenteric ganglia (Fig. 2 D and E) . Furthermore, in NOS1-creER T2 :tdTomato mice induced with tamoxifen as before, this treatment significantly attenuated the previously noted loss of tdTomato-labeled nitrergic neurons (Fig. 2F) (mean numbers ± SE of tdTomato + neurons per myenteric ganglia in pan-caspase inhibitor treated mice at day 7 posttamoxifen: 5.20 ± 0.50). As predicted, this arrest in death of nitrergic neurons also resulted in a significant increase in the global numbers of neurons (as measured by HuC/D + expression) (Fig. 2F) (mean numbers ± SE of HuC/D + neurons in a ganglia: 31.39 ± 1.57 vs. 19.33 ± 2.36 at day 7 posttamoxifen with and without zVAD-FMK, respectively; P = 0.004).
Myenteric Neurons Are Continuously Phagocytosed by Muscularis
Macrophages in the Healthy Gut. We asked how dying neurons or neuronal debris resulting from this high rate of neuronal death are cleared away from the myenteric ganglia. Such a high rate of neuronal death necessitates an equally efficient method of clearance by phagocytic cells. A specialized subset of intestinal macrophages, known as muscularis macrophages, are anatomically and functionally associated with the myenteric plexus (33, 34) . Because macrophages do not express the gene for choline acetyltransferase (ChAT) (35, 36) , which is expressed by a large number of myenteric neurons (35), we used the ChAT-cre:tdTomato mouse to observe the phagocytosis of myenteric neurons by muscularis macrophages. On imaging the myenteric plexus of these mice when stained with antibodies against macrophages, we observed that cell bodies of tdTomato-expressing cholinergic neurons were engulfed by muscularis macrophages in both the small intestine and the colon (Fig. 3, Fig. S1 C and D, and Movie S1). Although we were able to observe engulfment of neurons by these macrophages through microscopy, we also studied the presence of tdTomato inclusions in intestinal macrophages using flow cytometry and found that although the mucosal and submucosal macrophages that are less associated with enteric neurons (33) showed a very small population of tdTomato-containing macrophages, significant numbers (∼7.5%) of myenteric plexus-associated muscularis macrophages contained tdTomato in both small and large bowel, further supporting our imaging data ( Fig. S1 E and F) . Taking these data together, we observed that ENS-associated muscularis macrophages participate in phagocytosis of dying neurons and the active clearance of neuronal debris, and that this process is common for the both the small and large bowel.
Nestin Marks Putative ENPCs. Together, the above-mentioned results on conservation of total neuronal numbers, despite significant ongoing neuronal loss, provide robust evidence of significant neuronal turnover in healthy tissue, thereby indicating an active pool of ENPC. We next identified such cells using Nestin, a cytoskeletal protein (37) that is expressed by a variety of neural stem cells (38) (39) (40) (41) (42) . tdTomato Anatomical Location of ENPC in the Adult Intestine. Having proven that Nestin is a suitable marker for ENPC, we then proceeded to determine the location of putative ENPC in vivo using a Nestin-GFP transgenic reporter mouse that one of our laboratories has previously described (39). Using previously described techniques for optical clarification-aided microscopy of intestinal tissue (43), Nestin-GFP + cells in these mice form an extensive network of cells ( Fig. 5C ; unmerged images in Fig. S4A ), and hence do not qualify as neural crest-derived precursors. Instead, they express NG2 (Fig.  S4B ), a characteristic marker of intestinal pericytes derived from serosal mesothelium (46) . In contrast, Nestin-GFP + cells in the myenteric plexus are labeled with Wnt1-cre:tdTomato, indicating their origin from the neural crest. The intraganglionic Nestin-GFP + cells do not express the pan-neuronal marker PGP9.5 ( Fig.  5D ) and instead surround neuronal cell bodies ( Fig. S5C and Movie S3). However, they express the low-affinity nerve growth factor receptor, p75NTR ( Fig. 5E ; unmerged images in Fig. S4D ), CD49b ( Fig. 5F ; unmerged images in Fig. S4C ), and the glial marker, S100β (Fig. S5C ), both of which are known to mark cells that give rise to enteric neurons and glia or neurospheres in vitro (7, 8, 13) . In contrast, perivascular Nestin-GFP + cells do not express p75NTR. Finally, Nestin + cells express the mitotic marker Ki67 at steady state ( Fig. 5G ; unmerged images in Fig. S4G ) (mean ± SE numbers of myenteric ganglia with Nestin-GFP + cells that coexpress Ki67: 0.44 ± 0.14), suggesting that these cells are actively proliferating.
Myenteric Nestin
Having established the location of these putative ENPC, we next obtained definitive proof of their stem cell-like behavior using in vitro clonal assays in a defined culture medium (12, 40) . By establishing the flow gates for p75NTR-expressing cells (Fig. 6A) , we confirmed the coexpression of p75NTR in a subset of Nestin-GFP + cells using FACS analysis ( Fig. 6B and Fig. S2B ). In vitro clonal analyses on all isolated myenteric cell populations showed that only Nestin-GFP + cells proliferated ( Fig. 6C ) (mean ± SE of percentage of neurosphere-forming Nestin-GFP + cells: 3.6 ± 0.4). Using similar clonal analysis on Nestin-GFP + cells stained for p75NTR, we found that only cells labeled for both Nestin-GFP + and p75NTR
+ formed neurospheres (Fig. 6D ). This population shows significant enrichment in the numbers of neurosphereforming cells over its parent population of all Nestin-GFP + cells (mean ± SE of percentage of neurosphere-forming proliferative cells when sorted for Nestin-GFP and p75NTR: 10.1 ± 0.5; P < 0.01). Furthermore, these single cell-derived neurospheres produced both neurons and glia in differentiating conditions ( Fig. 6E ; unmerged monochrome images in Fig. S4K Fig. S5 A and B) , we hypothesized that they can give rise to new neurons in a classic stem cell paradigm where the precursor cell divides to form a daughter cell that then differentiates into a neuron, rather than by direct transdifferentiation without an intermediate cell division. We therefore determined if mature neurons were derived from proliferating cells, which would indicate the former process. Under resting conditions, a stem cell divides asymmetrically to produce a precursor cell and another stem cell. The former goes on to differentiate into a mature cell, whereas the latter reenters the cell-cycle after a period. Hence, by using temporally spaced proliferation markers, both the original stem cell and its daughter stem cell can be labeled and their fate followed in vivo.
We first optimized experimental protocols to detect thymidine analogs by using a variety of denaturation protocols (47) and then tweaking them for sectioned and whole-mount intestinal tissue. We administered IdU to an adult C57/Bl6 mouse for 7 consecutive days through drinking water and killed it at the end of 7 d of treatment. After rigorous denaturation (100 mM citrate buffer, pH 6.0, boiled for 2.5 min) of the tissue, IdU-labeled cells within the myenteric plexus were found within cross-sections of the ileum that expressed the pan-neuronal marker PGP9.5, and hence were neurons ( Fig. 8A and Fig. S4 I and J) . Cells within the intestinal crypts were also found to be labeled with IdU (Fig. 8A) validating our method.
Nestin-creER
T2
:tdTomato mice were then given a single dose of tamoxifen, followed a day later by a week-long pulse of IdU and in turn followed by a week-long pulse of a different thymidine analog, CldU, immediately after which the mice were killed. Both IdU and CldU are detected by anti-BrdU antibodies that selectively cross-react to either IdU or CldU (48) . If our hypothesis was correct, then during the first week, stem cells should take up IdU, and if they undergo asymmetrical division, then both the differentiated and the daughter stem cells will be labeled with IdU. Subsequent exposure to another label (CldU) will then result in only the proliferating daughter stem cell to carry both (IdU and CldU) labels that will in turn be expressed by their differentiated progeny cells. Fig. 8B shows a Nestin-derived (tdTomato + ) neuron that stains for both IdU and CldU, suggesting that this particular neuron was derived from a Nestin-expressing ENPC that cycled at least twice in the 2 wk after tamoxifen induction to generate a neuron. As shown in Fig. 8C , of all of the HuC/D + neurons, an average of 11.5% of neurons had no label, and hence were born before the 2-wk experiment; an average of 17% were only labeled with IdU and therefore were born from cells that cycled in the first week; 66% were labeled with both IdU and CldU, and therefore were born from cells that cycled at least twice in 2 wk and 4.75% were labeled with only CldU, suggesting that they were born from cells that cycled in the second week and had either already diluted their IdU label or never had it to begin with. Thus, ∼88% of all myenteric ganglia neurons that were labeled with HuC/D are only 2-wk-old, indicating a high rate of neurogenesis. Despite the evidence of copious neurogenesis, we found as before (Fig. 2F) , that the numbers of neurons in myenteric ganglia remains constant during this entire time (Fig. 8D) , consistent with ongoing attrition from apoptosis shown previously.
Targeted Deletion of Phosphatase and Tensin Homolog in Adult ENPCs
Reproduces the Phenotype of Some Forms of Chronic Intestinal PseudoObstruction. If enteric neurons are derived from proliferating Nestin + cells, then changes in their cycling behavior should disrupt ENS morphology and function. We have previously shown that changes in phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling in putative adult ENPC in an in vitro model results in increased ENPC proliferation (40) . We therefore deleted the PTEN gene in adult Nestin-expressing cells using Nestin-PTEN cKO mice. After tamoxifen induction, small intestinal myenteric ganglia in the Nestin-PTEN cKO mice were larger than those in the Nestin-PTEN WT mice ( Fig. 9 A and B) , with a significant increase in both the average numbers of neurons per ganglia (n = 3 mice per group, mean ± SE numbers neurons per ganglia: 17.79 ± 1.3 and 41.25 ± 3.4 for PTEN WT and PTEN cKO, respectively, P = 0.003) (Fig. 9C ) and the size of neuronal soma [n = 3 mice per group, mean ± SE soma size (measured as Feret diameter): 15.4 ± 0.44 μm and 20.00 ± 0.41 μm for PTEN WT and PTEN cKO, respectively, P = 0.001] (Fig. 9D) . In addition, we found that the whole-gut transit time for PTEN cKO mice was significantly more than PTEN WT animals (n = 8 mice per PTEN cKO group and n = 3 per PTEN WT group, mean ± SE gastrointestinal transit time of dye: 158.8 ± 20.17 min and 231.7 ± 14.33 min for PTEN WT and PTEN cKO, respectively; MannWhitney test: P = 0.04) (Fig. 9E) .
Relationship of ENPC to Glia. Given their expression of S100β, it is conceivable that ENPC are glial cells. To test this hypothesis, we studied the coexpression of Nestin and Sox10. Sox10 is expressed by neurogenic migrating ENPC during embryogenesis and development, but in adults it only marks mature enteric glia (8, 44) . For this experiment, we used adult Sox10-H2BVenus mice, in which all myenteric Sox10-expressing cells are labeled with the fluorescent reporter protein Venus (44) . When stained for Nestin, myenteric ganglia from these mice showed no detectable overlap between Sox10 and Nestin (Fig. S6A) . We further tested the expression of conventional glial markers GFAP and S100β in the Nestin-GFP
+ ENPC population in adult mice using FACS analysis. Although Nestin-GFP + p75NTR + cells express GFAP and S100β, not all GFAP + or S100β + cells expressed either Nestin-GFP or high levels of p75NTR (Fig. S6 B-G) . Thus, expression of GFAP or S100β by themselves is not sufficient to identify the adult ENPC. Our results, together with data from other studies (49, 50) , suggests that true glia express Sox10, whereas ENPC do not. Adult ENPC are therefore not enteric glia, although they express certain genes also associated with enteric glia.
Discussion
Although neurogenic cells have been shown to exist in adult murine and human gut, the demonstration of their stem-cell like behavior has been mainly restricted to in vitro experiments (7, 12, 13, 22, 40, (51) (52) (53) . Until now, most studies have suggested that there is no adult enteric neurogenesis in vivo in the healthy gut (7-9, 54). However, in the presence of ongoing neuronal loss and degeneration, as shown in a recent report (27), we do not know how adult myenteric neuronal numbers can be maintained for much of the adult life. Given the conflicting reports on this topic in the literature (5, 6, 26, (55) (56) (57) (58) , it was first important to rigorously establish and quantify apoptosis in adult enteric neurons. The use of multiple protocols for testing the presence of apoptotic neurons allowed us to confidently prove a high rate of myenteric neuronal apoptosis in the healthy gut. Approximately 11% of myenteric neurons at any one time are labeled by cleaved caspase-3, suggesting that they are fated for programmed cell death. We also found that significantly high (∼31%) numbers of labeled neurons were lost in a 7-d period, translating into a 4-5% loss of per day. The fact that approximately half the numbers that are fated for apoptosis (by cleaved caspase-3 labeling) die daily implies that it takes about 2 d for a neuron to die after initiation of apoptosis, which is consistent with what has been previously reported for other kinds of neurons (59) . The physiological role of apoptosis was highlighted by the use of a caspase inhibitor, which resulted in an increase in myenteric neuronal counts. Finally, we also show the presence of a robust phagocytic response driven by the abundant numbers of muscularis macrophages, which are known to be associated with myenteric neurons (33) , to clear the debris left from the significant numbers of dying neurons. Together, these results show a high turnover of enteric neurons in the adult gut, which can only be reconciled by invoking ongoing neurogenesis, which in turn necessitates the existence of an ENPC. Previous attempts to define adult ENPC have relied on in vitro demonstration of stem-cell like behavior of cells expressing various markers, such as Sox10, GFAP, p75NTR and CD49b, and Nestin (7-9, 11-18, 20-23) . Among these markers, we focused on Nestin because of the existence of transgenic animals expressing the Cre recombinase enzyme under the nestin promoter, allowing us to visualize and isolate these cells, follow their fate in vivo and genetically manipulate the expression of other proteins in them (38, 39, 41, 42) . Using Nestin-GFP transgenic reporter mice, we show that cells that coexpress Nestin with the neural crest stem cell marker, p75NTR, do not express neuronal markers and are located within the myenteric ganglia. This is the only cell population that is capable of proliferation and neurogenesis in vitro in defined culture conditions. By following the fate of these cells in adult inducible Nestin-creER
T2
:tdTomato mice, we found that Nestin-expressing cells gave rise to adult myenteric neurons in the healthy gut, suggesting that these cells are the true ENPC. A previous study has described a putative ENPC in the adult murine colon and suggested proliferation and migration into the myenteric plexus from an extraganglionic location after treatment with a 5HT4 agonist (9) . More recently, extraganglionic Schwann cell precursors were observed to generate myenteric neurons in the colon, but not in the small intestine (45) . In contrast to these two studies, we show that adult Nestin + precursors for small intestinal myenteric neurons are present inside the myenteric ganglia, suggesting regional differences in enteric neurogenesis.
Our results also suggest that true ENPC are not mature enteric glia, as was previously suggested (60) . Although Sox10-expressing cells in the adult myenteric plexus layer retain neurogenic properties in vitro (44) , such ability in vivo at steady state remains restricted to embryonic and early postnatal stages (8) . Somewhere between the two phases of embryonic ENS "development" and adult ENS "maintenance," there is a switch in ENPC marker profile from Sox10 to Nestin. Indeed, recent work in zebrafish ENS development shows that the neural precursors in the developing gut are also heterogeneous for their Sox10 expression, with neurogenic Sox10
− cells present behind the migrating wave front of Sox10 + multipotent enteric neural crest precursors (61) . Together with our findings, these reports lead to a plausible hypothesis that Sox10
+ mature glial cells in the adult gut have restricted ability to generate neurons in vivo and only under certain injurious conditions (8) , whereas Nestin
− precursors are responsible for adult neurogenesis in health.
Definitive proof of the precursor nature of these cells was their ability, under conditions that promoted unchecked proliferation, to reproduce the phenotype of certain human diseases. A change in enteric neuronal number is associated with chronic intestinal pseudo-obstruction, a chronic debilitating condition with slow intestinal motility and related complications. Both decreases (hypoganglionisis) and increases (hyperganglionosis) in myenteric neurons have been associated with chronic intestinal pseudoobstruction. The latter include several human conditions, such as intestinal neuronal dysplasia (IND) or ganglioneuromatosis, which are probably heterogeneous disorders with subsets of patients showing marked reduction in the expression of PTEN (24) . Taken together with our previous in vitro results that adult ENPC cycle and generate neurons in a PTEN-dependent manner (40) , the present work suggests that adult neurogenesis in vivo may also be controlled by a molecular pathway involving PTEN expression. We recognize that our findings contradict current dogma in the field, which postulates that populations of adult enteric neurons, once born, remain static until death by disease or senescence. Indeed, previous reports have apparently failed to find evidence of neurogenesis by following the fate of adult Sox10-expressing cells that were assumed to be adult ENPC (8) . This discrepancy can now be explained by our demonstration that ENPC do not express Sox10. On the other hand, ENPC do express glial markers like GFAP and others have attempted to use GFAP for fate-mapping experiments in adult neurons, with results that also apparently conflict with ours (7). These investigators used an adult inducible transgenic hGFAP-creER T2 mouse bred with a floxed YFP reporter transgenic mouse on a B6 background that was given a long-term exposure to tamoxifen (6-8 mo). However, only 3-5% of GFAP + cells actually underwent tamoxifen-induced cre recombination to become YFP + . Given this reduced rate of transgene expression along with additional problems related to reporter expression with age (62), it is not surprising that these investigators saw a very small proportion of neurons that appeared to be derived from adult GFAP-YFP + cells. Furthermore, because all of the tamoxifen-induced hGFAP-creER T2 mice were killed at the same time of posttamoxifen treatment, Joseph et al. could not observe whether or not this GFAP-derived neuronal population expands with time (7) . Nevertheless, the fact that such low numbers of recombinant YFP + cells were still able to generate a population of neurons at steady state is consistent with our results.
In this report, we also addressed another discrepancy in the literature, namely the inability by Joseph et al. (7) to demonstrate in vivo neurogenesis using BrdU labeling. We next address the issue of why previous reports, using BrdU pulse-chase techniques, failed to demonstrate neurogenesis from cycling precursors , hence derived from precursor cells that cycled only once in either conditions, compared with neurons born with both labels, and hence derived from precursor cells that cycled in both the conditions to generate neurons. This finding suggests that the rate of cycling of the precursor cells is high. We also see a small population of neurons born from precursors that did not cycle during the experiment and hence were either born during the experiment but from cells that cycled just before the experiment or were born before the experiment. the myenteric ganglia proliferate in vivo, as indicated by their significant increase in numbers 6 d after being labeled at a clonal dose (**P < 0.001). (7, 8, 54) . We reasoned that if the ENPC population truly has a high turnover rate, decay of label-retention marker to below detection levels could have been a significant confounding factor (63) . We therefore designed a labeling and detection protocol for shorter chases and harsher DNA denaturation. Using these techniques for temporally dispersed administration of distinct thymidine analogs, we show that adult enteric neurogenesis results from cycling neural precursors that express Nestin. After 2 wk of treatment with the thymidine analogs, ∼88% of all neurons that were labeled with HuC/D showed evidence of label-retention, and hence were newly born. Although this number is very high, it helps explain how myenteric neuronal numbers can be maintained despite very high rates of neuronal apoptosis. When apoptosis was arrested, we saw an ∼50% increase in numbers of neurons per ganglia in a week, which reconciles with ∼88% of newborn neurons in 2 wk. The surprisingly high rate of neuronal turnover raises several questions that remain to be answered in future studies. Our results are confined to the small bowel and we do not know whether other regions of the gut express the same paradigm of neurogenesis. Our results with in vivo imaging show a rapidly changing neuronal network, indicating a highly dynamic nervous system that is constantly losing old connections and making new ones. At this time we do not fully understand how functional circuits are built or maintained in the ENS, but a likely explanation for the lack of physiological disruption from this turnover is that it is staggered in time and space, along with the significant redundancy of such circuits within a given region of the gut (64) (65) (66) (67) .
This rate of turnover in the ENS is either a result of an intrinsically short life of mature neurons or of injury from constant mechanical stress (tensile, compressive, and shear) exerted on the myenteric plexus by virtue of it being sandwiched between the longitudinal and circular muscle (3) . In addition, because of its proximity to bowel contents, the ENS is uniquely vulnerable to external threats (4, 68) . Nevertheless, a relatively small population of ENPC in the myenteric ganglia appears to be capable of replacing large numbers of dead or dying neurons. As our previous calculations show, adult myenteric neurons die at a rate of a single neuron per ganglia per day, which is not beyond the capacity of a rapidly cycling cell. An alternative mechanism involves a pool of intermediate "transit-amplifying" cells that are fate-committed and cycle to generate large numbers of terminally differentiated cells, as is done by the intestinal stem cells (69) . Whether such neurogenic transit-amplifying cells exist in the adult myenteric ganglia is not currently known, and understanding the differentiation pattern of ENPC to form adult neurons would be part of the next steps in understanding the complex biology of the adult ENS.
In conclusion, our study shows evidence of a robust and rapid turnover of adult enteric neurons from identifiable neuronal precursors that are not mature glial cells (Fig. S7) . These findings have considerable scientific and clinical significance. Reliance on this mechanism to maintain neuronal numbers in the presence of ongoing apoptosis may render the ENS at risk from disturbances in this process. For example, a recent study shows that the anticancer chemotherapeutic agent 5-FU, a thymidine synthesis blocker that targets cycling cells, causes a reduction in populations of adult myenteric neurons (70) . Similarly, reports of increased apoptosis in myenteric neurons in adult mice with high-fat diet-induced obesity (58) are not always associated with a corresponding loss of myenteric neurons, suggesting active replacement (71) . In another case of clinical and physiological relevance, aging is associated with both decreased presence (72) and proliferative potential of ENPC, as well as increased neuronal apoptosis (27) , which together could account for the observed reduction in neuronal numbers with age (64) . These reports can now be better understood in a construct where the ENS is dynamically maintained by a balance between apoptosis and neurogenesis. Furthermore, as we have shown, targeting genetic mutations in the identified ENPC has the potential for developing novel models of human disease. Therefore, by identifying the participating cells and their molecular profile, our study provides a scientific foundation to study the pathogenesis of disorders of motility, as well as therapeutic targets for the same. Tissue preparation was performed as described before (12, 40) , which along with immunohistochemistry (for antibodies see Table S1 ) and cell isolation protocols are described in SI Methods. Protocols for IdU and CldU labeling, detection, and quantification. Post tamoxifen induction, the mice were given 1 mg/mL of IdU by drinking water for 7 d, after which the IdU-laced drinking water was exchanged with drinking water containing 1 mg/mL of CldU for 7 more days. The mice were then killed, and LM-MP preparations (see below) fixed in freshly made ice cold 4% paraformaldehyde solution. For the whole-mount stainings, we tested denaturation with 10% EDTA (47) at both room temperature and at elevated temperatures (50°C) for 15 min and found the tissue unresponsive to any immunohistochemistry using either the BrdU antibodies or the anti-HuC/D sera. These experiments with EDTA were followed by testing CldU and HuC/D immunostaining with control tissue (from animals without exposure to CldU) and test tissue (from animals dosed with CldU for 1 wk) that were exposed to 2 N HCl at 50°C for varying amounts of time (5, 10, and 15 min), and then were immediately washed after thrice with 1× PBS (15 min per wash). The control tissues did not give any reaction to CldU antibodies, whereas the test tissues saw an increase in the numbers of cells around and within the myenteric ganglia with exposure to the denaturing agent ( Fig. S3 B and C). Exposure to 2 N HCl at elevated temperatures beyond 15-min hampered tissue integrity and created impediment to immunostaining and visualization. This standardized protocol was used for immunostaining the IdU/ CldU-stained tissues. IdU/CldU was then labeled with anti-BrdU antibodies that selectively cross-label either IdU or CldU [B44 antibody selectively cross-reacts with IdU (BD Biosciences) and Bu1/75 selectively cross-reacts with CldU (Novus Biologicals)] (48) and counterstained with anti-mouse 546 antibody (against B44
IdU antibody) and anti-rat 488 antibody (against Bu1/75 CldU antibody) (Invitrogen). The acid treatment destroys all native fluorescence and changes cell structure, so tdTomato expression needs to be revealed by immunofluorescence. Hence, the tissues were stained with anti-RFP antibody (Rockland) in addition to HuC/D antisera (ANNA1). The anti-RFP antibody was counterstained with antirabbit 647 antibody (Invitrogen) and the HuC/D antisera was counterstained with anti-human Brilliant Violet 421 antibody (Biolegend). The tissues were mounted with mounting medium without DAPI (Vector Labs). Control tissues of LM-MP that were never dosed with IdU/CldU were similarly denatured and stained. Slight staining in the nucleoli was regarded as a denaturation-based autofluorescence, but copious staining in the whole nucleus in a HuC/D-labeled cell was deemed as a positively labeled neuron. As a technical limitation of performing acid treatment, a prerequisite of staining for label-retention, on whole mounts of intestines to visualize and enumerate enteric neurons, the size and shape of cells is changed and not all neurons are labeled with HuC/D. Hence, for the quantification, only neurons labeled convincingly with HuC/D antisera are counted, and hence represent a subpopulation of all myenteric neurons. Detecting apoptosis in enteric neurons. Fixed LM-MP tissues from an adult C57BL/6 mouse were stained for cleaved caspase-3, a marker for apoptosis using the antibody Asp175 (Cell Signaling). The tissues were counterstained with DAPI, overlaid with Vectashield mounting medium (Vector Labs), coverslipped, and imaged using a Leica 510 confocal microscope. The images then were analyzed using Fiji software (fiji.sc). A HuC/D-labeled cell in the myenteric ganglia with strong immunostaining for cleaved caspase-3 in the perinuclear space (26, 56, 73) was counted as an apoptotic neuron. Other methods for detecting apoptotic neurons are presented in SI Methods. Small intestinal ganglia were demarcated as previously described (27) and their neuronal density was represented as neurons/ganglia as previously reported (74) . Imaging experiments. Protocols for fixed tissue confocal imaging, live animal confocal imaging, as well as two-photon imaging experiments are described in SI Methods.
Statistics. All the quantified data is presented in Tables S2-S8 . Data are expressed as the mean ± SE for every graphical representation. Statistical analysis was performed with the aid of Graphpad Prism. A Mann-Whitney test and and Kruskall-Wallis test were used to compare means for statistically significant difference between two and three groups, respectively. Statistical significance (*) was assumed if P < 0.05.
